JP2023156353A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023156353A5 JP2023156353A5 JP2023121818A JP2023121818A JP2023156353A5 JP 2023156353 A5 JP2023156353 A5 JP 2023156353A5 JP 2023121818 A JP2023121818 A JP 2023121818A JP 2023121818 A JP2023121818 A JP 2023121818A JP 2023156353 A5 JP2023156353 A5 JP 2023156353A5
- Authority
- JP
- Japan
- Prior art keywords
- residue
- isolated
- amino acid
- purified peptide
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017903381A AU2017903381A0 (en) | 2017-08-22 | Screening Assays, Modulators and Modulation of Activation of Receptor For Advanced Glycation End-Products (RAGE) | |
| AU2017903381 | 2017-08-22 | ||
| AU2018902298A AU2018902298A0 (en) | 2018-06-26 | Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) | |
| AU2018902298 | 2018-06-26 | ||
| JP2020511214A JP2020531514A (ja) | 2017-08-22 | 2018-08-21 | 終末糖化産物受容体（ｒａｇｅ）の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
| PCT/AU2018/050883 WO2019036753A1 (en) | 2017-08-22 | 2018-08-21 | SCREENING TESTS, MODULATORS AND MODULATION OF RECEIVER ACTIVATION FOR ADVANCED GLYCATION TERMINAL PRODUCTS (RAGE) |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511214A Division JP2020531514A (ja) | 2017-08-22 | 2018-08-21 | 終末糖化産物受容体（ｒａｇｅ）の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023156353A JP2023156353A (ja) | 2023-10-24 |
| JP2023156353A5 true JP2023156353A5 (https=) | 2024-02-21 |
| JP7855180B2 JP7855180B2 (ja) | 2026-05-08 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006149365A5 (https=) | ||
| JP2019535268A5 (ja) | アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物 | |
| JP2002500043A5 (https=) | ||
| JP2012082206A5 (https=) | ||
| JP2020503262A5 (ja) | アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物 | |
| JP2002502589A5 (https=) | ||
| JP2023528207A5 (https=) | ||
| JP2018538356A5 (https=) | ||
| WO2014081702A4 (en) | Synthetic linear apelin mimetics for the treatment of heart failure | |
| JP2016501851A5 (https=) | ||
| JP2002506625A5 (https=) | ||
| JP2020517260A5 (https=) | ||
| JP2023542453A5 (https=) | ||
| FI4034555T3 (fi) | Dap10/dap12-fuusiopolypeptidit | |
| JP2026035742A5 (https=) | ||
| RU2010141916A (ru) | Растворимый мутант рецептора фактора некроза опухоли | |
| JP2004505640A5 (https=) | ||
| JP2023156353A5 (https=) | ||
| JP2004537284A5 (https=) | ||
| JP2024526356A5 (https=) | ||
| JP2001515720A (ja) | β−デフェンシン | |
| JP2002539829A5 (https=) | ||
| AU779261B2 (en) | Bone stimulating factor | |
| WO1992014834A1 (en) | Insulin-like growth factor binding protein | |
| JPWO2023282281A5 (https=) |